Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.

MLA

Tantawy, Shady I., et al. “Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 2, Jan. 2023, pp. 446–57. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-22-2088.

APA

Tantawy, S. I., Sarkar, A., Hubner, S., Tan, Z., Wierda, W. G., Eldeib, A., Zhang, S., Kornblau, S., & Gandhi, V. (2023). Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 29(2), 446–457. https://doi.org/10.1158/1078-0432.CCR-22-2088

Chicago

Tantawy, Shady I, Aloke Sarkar, Stefan Hubner, Zhi Tan, William G Wierda, Abdelraouf Eldeib, Shuxing Zhang, Steven Kornblau, and Varsha Gandhi. 2023. “Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29 (2): 446–57. doi:10.1158/1078-0432.CCR-22-2088.